StockTalk is a Stockhead video series featuring a roundtable of experts discussing a new investment topic each week. In this edition, host Dr Nigel Finch discusses skyrocketing healthcare spending and its impact on the medtech sub-sector.
The group discusses a range of topics, including how the medtech sector has reacted to increased funding, if the trend will continue post COVID-19, which firms are capitalising, which regions are primed for medtech adoption, the question of affordability and more.
So tune in above to hear the panel discuss these questions.
The post StockTalk: How are ASX medtechs responding to skyrocketing healthcare spending? appeared first on Stockhead.
Barry Stroman was a reporter for Zerg Watch, before becoming the lead editor. Barry has previously worked for Wired, MacWorld, PCWorld, and VentureBeat covering countless stories concerning all things related to tech and science. Barry studied at NYU.